Shennon Biotechnologies
PrivateLast Round
Early Funding
Sep 14, 2026
Total Funding Raised
$25M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Shennon Biotechnologies is a biotechnology company that develops precision immunotherapies for cancer using a proprietary single-cell functional screening platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shennon Biotechnologies Comparables
Compare Shennon Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BigHat Biosciences | 78% | |
| A-Alpha Bio | 78% | |
| LabGenius Therapeutics | 78% |
Shennon Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Sep 14, 2026 | ||||
| Seed | Mar 13, 2023 |
Shennon Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Foundation Capital | Seed, Early Funding |
| Saras Capital | Early Funding |
| Atypical | Early Funding |
| Future Ventures | Early Funding |
| Samos Investments | Early Funding |
| AV8 Ventures | Seed, Early Funding |
| NextGen Venture Partners | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 14, 2026
$12M raised from DCVC, Atypical, and others.
- Jul 20, 2026
Open roles increased to 37, 231% of headcount.
Recent news
Latest coverage and updates
- launchesSep 14, 2026
ShennonBio launched Precision Immunotherapy pipeline on Sep 14th '26.
- is_developingSep 14, 2026
ShennonBio is developing TCR-based T-cell engagers.
- receives_financingSep 14, 2026
ShennonBio received financing of $12M in Seed on Sep 14th '26.
- hiresSep 14, 2026
ShennonBio hired Cyril Konto as Chief Executive Officer on Sep 14th '26.
Shennon Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Shennon Biotechnologies's valuation, stock price, and market status.
Is Shennon Biotechnologies a public or private company?
Shennon Biotechnologies is a private company.
What is the current stock price of Shennon Biotechnologies?
Shennon Biotechnologies is a private company, so its shares have no public market price. Caplight tracks Shennon Biotechnologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shennon Biotechnologies worth (valuation)?
Valuation information for Shennon Biotechnologies is not publicly available.
Can I buy Shennon Biotechnologies stock?
Shennon Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shennon Biotechnologies's last funding round?
Shennon Biotechnologies's most recent funding round was Early Funding on September 14, 2026.
Who are the main investors in Shennon Biotechnologies?
Key investors in Shennon Biotechnologies include DCVC (Data Collective).
Will Shennon Biotechnologies IPO soon?
No public IPO plans have been announced for Shennon Biotechnologies.
How can I track Shennon Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades in Shennon Biotechnologies's shares on secondary markets.